18 research outputs found
Use of artificial nutrition near the end of life: Results from a French national population-based study of hospitalized cancer patients
International audienceBackgroundThe use of artificial nutrition, defined as a medical treatment that allows a nonâoral mechanical feeding, for cancer patients with limited life expectancy is deemed nonbeneficial. Highâquality evidence about the use of artificial nutrition near the end of life is lacking. This study aimed (a) to quantify the use of artificial nutrition near the endâofâlife, and (b) to identify the factors associated with the use of artificial nutrition.MethodsThis was a retrospective cohort study of decedents based on data from the French national hospital database. The study population included adult cancer patients who died in hospitals in France between 2013 and 2016 and defined to be in a palliative condition. Use of artificial nutrition during the last 7 days before death was the primary endpoint.ResultsA total of 398 822 patients were included. The median duration of the last hospital stay was 10 (interquartile range, 4â21) days. The artificial nutrition was used for 11 723 (2.9%) during the last 7 days before death. Being a man, younger, having digestive cancers, metastasis, comorbidities, malnutrition, absence of dementia, and palliative care use were the main factors associated to the use of artificial nutrition.ConclusionThis study indicates that the use of artificial nutrition near the end of life is in keeping with current clinical guidelines. The identification of factors associated with the use of artificial nutrition, such as cancer localization, presence of comorbidities or specific symptoms, may help to better manage its use
Lessons from end-of-life care among schizophrenia patients with cancer: a population- based cohort study from the French national hospital database Running title: End-of-life care among patients with schizophrenia and cancer
International audienceBackgroundPatients with schizophrenia represent a vulnerable, underserved, and undertreated population who have been neglected in health disparities work. Understanding of end-of-life care in patients with schizophrenia and cancer is poor. We aimed to establish whether end-of-life care delivered to patients with schizophrenia and cancer differed from that delivered to patients with cancer who do not have diagnosed mental illness.MethodsWe did a population-based cohort study of all patients older than 15 years who had a diagnosis of advanced cancer and who died in hospital in France between Jan 1, 2013, and Dec 31, 2016. We divided this population into cases (ie, patients with schizophrenia) and controls (ie, patients without a diagnosis of mental illness) and compared access to palliative care and indicators of high-intensity end-of-life care between groups. In addition to unmatched analyses, we also did matched analyses (matched in terms of age at death, sex, and site of primary cancer) between patients with schizophrenia and matched controls (1:4). Multivariable generalised linear models were done with adjustment for social deprivation, year of death, time from cancer diagnosis to death, metastases, comorbidity, and hospital type (ie, specialist cancer centre vs non-specialist centre).FindingsThe main analysis included 2481 patients with schizophrenia and 222â477 controls. The matched analyses included 2477 patients with schizophrenia and 9896 controls. Patients with schizophrenia were more likely to receive palliative care in the last 31 days of life (adjusted odds ratio 1·61 [95% CI 1·45â1·80]; p<0·0001) and less likely to receive high-intensity end-of-life careâsuch as chemotherapy and surgeryâthan were matched controls without a diagnosis of mental illness. Patients with schizophrenia were also more likely to die younger, had a shorter duration between cancer diagnosis and death, and were more likely to have thoracic cancers and comorbidities than were controls.InterpretationOur findings suggest the existence of disparities in health and health care between patients with schizophrenia and patients without a diagnosis of mental illness. These findings underscore the need for better understanding of health inequalities so that effective interventions can be developed for this vulnerable population
Epidemiology of trauma in France: mortality and risk factors based on a national medico-administrative database
In industrialised countries, trauma is a public health challenge. Despite disposing of a highly evolved and complex health care system, France does not dispose of a national trauma registry or trauma system. Little is known about the epidemiology of trauma in France. This study aims at describing, using the national billing database, the epidemiology of French trauma.MethodsA retrospective population-based cohort study has been conducted on trauma patients in France using the National Hospital Discharge Data Set Database for 2016. Patients were selected using the Trauma Audit and Research Network (TARN) criteria, inspired by the UK trauma system. Sociodemographic, clinical information and hospital characteristics were collected. The main outcome was 30-day mortality.ResultsAmong 1,144,596 patients hospitalised in French hospitals for trauma in 2016, 144,058 patients were included based on the TARN criteria. The mean age of the patients was 64?years (±?24). Women (50.8%) were over-represented among patients older than 75 years. The 30-day mortality was 5.9%, and regional variations were identified. In multivariate analysis, age, gender, area-level deprivation, injury localisation, co-morbidities, injury severity, transfusion, surgery, and ICU admission were independent factors of risk for 30-day mortality. Age and injury severity were the stronger predictors for mortality and area-level deprivation was associated with higher mortality.ConclusionThe national burden of trauma care was assessed with medico-administrative data in a country without a trauma system. The 30-day mortality associated with trauma in France was around 6%, with regional variations
Observation des pharmacodépendances en médecine ambulatoire : le programme OPEMA
Objectif. Cette étude présente le programme Observations des
pharmacodépendances en médecine ambulatoire (OPEMA) et les principaux résultats de sa
derniĂšre enquĂȘte (novembre 2010). MĂ©thode. Les informations recueillies
concernent la situation sociodémographique des sujets, leur état de santé et leur
consommation actuelle de substances psychoactives. RĂ©sultats. En 2010, 1 394
sujets ont Ă©tĂ© inclus, dĂ©crivant la consommation de 2 450 substances. Leur moyenne dâĂąge
est de 38,2 ± 12,7 ans. Quatre-vingt-six pour cent disposent dâun logement stable et 52 %
exercent une activité professionnelle. Cinquante-six pour cent des sujets présentent une
comorbidité psychiatrique. Parmi les sujets inclus, les prévalences du VIH et du VHC sont
de 3 % et 20 %. Quarante-cinq pour cent des sujets inclus ont été injecteurs de substances
psychoactives, dont 6 % actuellement. Quatre-vingt-deux pour cent sont consommateurs de
traitement de substitution de la dépendance aux opiacés et 29 % de benzodiazépines.
Conclusion. Le programme OPEMA complĂšte le dispositif dâaddictovigilance en
recueillant des données en provenance des médecins généralistes, et favorise une
connaissance globale de lâĂ©tat de santĂ© des sujets pharmacodĂ©pendants
Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey
International audienceThe objective of the study was to determine which psychoactive prescription drugs are illegally obtained and through which ways of acquisition. OPPIDUM is an annual national study. It is based on specialized care centers that included subjects presenting a drug dependency or under opiate maintenance treatment. All their psychoactive substances consumed are reported. This work focuses on the different ways of acquisition specially the illegal ways of acquisition (bought on the street, forged prescription, stolen, given, internet). For each medication illegally obtained, a ratio has been calculated (number of illegal acquisitions divided by the number of described acquisitions). In 2008, 5542 subjects have been included and have described the consumption of 11 027 substances including 63.8% of prescription drugs. Among them, 11% were illegally obtained. The different illegal acquisition ways were 'street market' (77.6%), 'gift' (16.6%), 'theft' (2.3%), 'forged prescription' (2.3%), and 'internet' (0.7%). The third first drugs illegally obtained were high dosage buprenorphine, methadone, and clonazepam. Some prescription drugs, less consumed, have an important ratio of illegal acquisition like ketamine, flunitrazepam, morphine, trihexyphenidyl, or methylphenidate. This study confirms that theft, forged prescription and internet are few used and permits to highlight diversion of prescription drugs. It is important to inform healthcare professionals on the different prescription drugs that are illegally obtained
Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database
International audienc
Machine-learning prediction of unplanned 30-day rehospitalization using the French hospital medico-administrative database
International audienc
Intensive end-of-life care in acute leukemia from a French national hospital database study (2017â2018)
International audienceBackground: A better understanding of how the care of acute leukemia patients is managed in the last days of life would help clinicians and health policy makers improve the quality of end-of-life care. This study aimed: (i) to describe the intensity of end-of-life care among patients with acute leukemia who died in the hospital (2017â2018) and (ii) to identify the factors associated with the intensity of end-of-life care.Methods This was a retrospective cohort study of decedents based on data from the French national hospital database. The population included patients with acute leukemia who died during a hospital stay between 2017 and 2018, in a palliative care situation (code palliative care Z515 and-or being in a inpatient palliative care support bed during the 3 months preceding death). Intensity end-of-life care was assessed using two endpoints: High intensive end-of-life (HI-EOL: intensive care unit admission, emergency department admission, acute care hospitalization, intravenous chemotherapy) care and most invasive end-of-life (MI-EOL: orotracheal intubation, mechanical ventilation, artificial feeding, cardiopulmonary resuscitation, gastrostomy, or hemodialysis) care.Results A total of 3658 patients were included. In the last 30âdays of life, 63 and 13% of the patients received HI-EOL care and MI-EOL care, respectively. Being younger, having comorbidities, being care managed in a specialized hospital, and a lower time in a palliative care structure were the main factors associated with HI-EOL.Conclusions A large majority of French young adults and adults with acute leukemia who died at the hospital experienced high intensity end-of-life care. Identification of factors associated with high-intensity end-of-life care, such as the access to palliative care and specialized cancer center care management, may help to improve end-of-life care quality
Reduced mortality associated to cementless total hip arthroplasty in femoral neck fracture
Abstract Mortality related to femoral neck fractures remains a challenging health issue, with a high mortality rate at 1Â year of follow-up. Three modifiable factors appear to be under control of the surgeon: the choice of the implant, the use of cement and the timing before surgery. The aim of this research project was to study the impact on mortality each of these risk factors play during the management of femoral neck fractures. A large retrospective epidemiological study was performed using a national database of the public healthcare system. The inclusion criteria were patients who underwent joint replacement surgery after femoral neck fracture during the years 2015 to 2017. All data points were available for at least 2Â years after the fracture. The primary outcome was mortality within 2Â years following the surgery. We evaluated the association between mortality and the type of the implant hemiarthroplasty (HA) versus total hip arthroplasty (THA), cemented versus non cemented femoral stem as well as the timing from fracture to surgical procedure. A multivariate analysis was performed including age, gender, comorbidities/autonomy scores, social category, and obesity. We identified 96,184 patients who matched the inclusion criteria between 2015 and 2017. 64,106 (66%) patients underwent HA and 32,078 (33.4%) underwent THA. After multivariate analysis including age and comorbidities, patients who underwent surgery after 72Â h intra-hospital had a higher risk of mortality: Hazard Ratio (HR)â=â1.119 (1.056â1.185) pâ=â0.0001 compared to the group who underwent surgery within 24Â h. THA was found to be a protective factor HRâ=â0.762 (0.731â0.795) pâ<â0.0001. The use of cement was correlated with higher mortality rate: HRâ=â1.107 (1.067â1.149) pâ<â0.0001. Three key points are highlighted by our study in the reduction of mortality related to femoral neck fracture: the use of hemiarthroplasty a surgery performed after 48Â h and the use of cement for femoral stem fixation adversely affect mortality risk
Unplanned readmission and survival after video-assisted thoracic surgery and open thoracotomy in patients with non-small-cell lung cancer: a 12-month nationwide cohort study
Abstract OBJECTIVES To compare outcomes at 12âmonths between video-assisted thoracic surgery (VATS) and open thoracotomy (OT) in patients with non-small-cell lung cancer (NSCLC) using real-world evidence. METHODS We did a nationwide propensity-matched cohort study. We included all patients who had a diagnosis of NSCLC and who benefitted from lobectomy between 1 January 2015 and 31 December 2017. We divided this population into 2 groups (VATS and OT) and matched them using propensity scores based on patientsâ and hospitalsâ characteristics. Unplanned readmission, mortality, complications, length of stay and hospitalization costs within 12âmonths of follow-up were compared between the 2 groups. RESULTS A total of 13Â 027 patients from 180 hospitals were included, split into 6231 VATS (47.8%) and 6796 OT (52.2%). After propensity score matching (5617 patients in each group), VATS was not associated with a lower risk of unplanned readmission compared with OT [20.7% vs 21.9%, hazard ratio 1.03 (0.95â1.12)] during the 12-months follow-up. Unplanned readmissions at 90âdays were mainly due to pulmonary complications (particularly pleural effusion and pneumonia) and were associated with higher mortality at 12âmonths (13.4% vs 2.7%, Pâ<â0.0001). CONCLUSIONS VATS and OT were both associated with high incidence of unplanned readmissions within 12âmonths, requiring a better identification of prognosticators of unplanned readmissions. Our study highlights the need to improve prevention, early diagnosis and treatment of pulmonary complications in patients with VATS and OT after discharge. These findings call for improving the dissemination of systematic perioperative care pathway including efficient pulmonary physiotherapy and rehabilitation